Prolonged labour duration in women with pregestational diabetes: A Population-Based Cohort Study

Women with pregestational diabetes have increased rates of
adverse obstetric and perinatal outcomes, including congenital malformations,
preeclampsia, stillbirth, fetal macrosomia, and caesarean delivery compared to
women without diabetes. The risk of emergency caesarean section (CS) is 3–4
times higher compared to women without diabetes and despite therapeutic
initiatives and technological advancements, the overall CS rate in women with
pregestational diabetes remains persistently above 60%. A common indication for
elective CS in women with pregestational diabetes is macrosomia.

It is essential to specifically investigate active labour
duration in a well-defined cohort of women with pregestational diabetes and to
include emergency CS in order to explore whether prolonged labour contributes
to the elevated CS risk in this population. Authors hypothesised that
pregestational diabetes is associated with longer duration of active labour, in
addition to other known factors influencing labour progression. Therefore, the
aims of this study were to evaluate the impact of pregestational diabetes on
DAL in nulliparous women in induced and spontaneous onset of labour and to
compare CS indications and rates, -both elective and emergency, -with those of
women without diabetes.

It was a population-based cohort study in Sweden. 243 537
nulliparous women, registered in the Swedish Pregnancy Register, who delivered
a singleton fetus at ≥34+0 gestational weeks+days between 2014 and 2020 were
included. Women with gestational diabetes mellitus were excluded.

Women with pregestational diabetes had longer active labour
and a reduced chance of vaginal delivery at a given time point compared to
women without diabetes, adjusted hazard ratio 0.65 (p <0.001). Among those
with spontaneous labour, median DAL in diabetic vs. non-diabetic women was 9.60
h versus 8.75 h, difference 0.85 h, p <0.001. Corresponding numbers for
induced labours were 8.92 h versus 7.20 h, difference 1.72 h, p<0.001.
Elective and emergency CS rates were higher in women with pregestational
diabetes than non-diabetic women (7.4% and 29.4% vs. 2.6% and 7.1%
respectively), with suspected macrosomia (50.4%) and fetal distress (31.9%)
being the most common indications for CS among women with pregestational
diabetes.

In this nation-wide population-based cohort of nulliparous
women, we observed a longer duration of both spontaneous and induced active
labour in women with pregestational diabetes, as well as a reduced likelihood
of vaginal delivery at any given time during active labour, compared with women
without diabetes.

The prolonged labour duration in women with pregestational
diabetes highlights the significance of the labour ward staff’s support and
patience in managing diabetic parturients, potentially allowing more time
before diagnosing labour dystocia in this population. An extended period of
active labour may influence how women perceive their birth experience and
emphasises the importance of providing these women with comprehensive
information prior to labour.

Source: Sofia Nevander, Sara Carlhäll,
Karin Källén; BJOG: An International Journal of Obstetrics &
Gynaecology, 2025; 0:1–9 https://doi.org/10.1111/1471-0528.18276

Powered by WPeMatico

While it may go unnoticed, loss of smell may linger for years after COVID-19, reports study

People who suspect that their sense of smell has been dulled after a bout of COVID-19 are likely correct, a new study using an objective, 40-odor test shows. Even those who do not notice any olfactory issues may be impaired.

Led by the National Institutes of Health’s RECOVER initiative and supported by its Clinical Science Core at NYU Langone Health, a team of researchers from across the country explored a link between the coronavirus that causes COVID-19 and hyposmia — the reduced ability to smell.

The results revealed that 80% of participants who reported a change in their smelling ability after having COVID-19 earned low scores on a clinical scent-detection test taken about two years later. Of this group, 23% were severely impaired or had entirely lost their sense of smell.

Notably, 66% of infected participants who did not notice any smelling issues scored abnormally low on the evaluation as well, the authors say.

“Our findings confirm that those with a history of COVID-19 may be especially at risk for a weakened sense of smell, an issue that is already underrecognized among the general population,” said study co-lead author Leora Horwitz, MD.

Horwitz, a professor in the Departments of Population Health and Medicine at NYU Grossman School of Medicine, adds that 60% of uninfected participants who did not report olfactory problems also tested poorly during the clinical evaluation.

Hyposmia has long been connected to weight loss, reduced quality of life, and depression, among other concerns. Those with a diminished sense of smell may also struggle to detect dangers such as spoiled food, gas leaks, and smoke, experts say. In addition, scientists have flagged smelling dysfunction as an early sign of certain neurodegenerative disorders such as Parkinson’s disease and Alzheimer’s disease, which can affect the brain’s scent-processing region.

While past research has identified hyposmia as a symptom of coronavirus infection, most of these studies have relied on patients’ own assessments of their smelling ability. Such subjective measures are not always reliable and cannot effectively track the problem’s severity and persistence, notes Horwitz.

The new study in 3,535 men and women, publishing online Sept. 25 in the journal JAMA Network Open, is the largest to date to examine loss of smell after COVID-19 by using a formal test, the authors say.

Along with Horwitz, Jacqueline Becker, PhD at Icahn School of Medicine at Mount Sinai in New York is co-lead author. Hassan Ashktorab, PhD, at Howard University in Washington, D.C.; Andrea Foulkes, ScD, at Massachusetts General Hospital in Boston; and Joyce Lee-Iannotti, MD, at the University of Arizona in Phoenix, are study co-senior authors.

For the investigation, the research team assessed thousands of Americans who had participated in the RECOVER adult study, a multicenter analysis designed to shed light on the long-term health effects of the coronavirus. Throughout the study, those with and without a history of COVID-19 completed surveys about their symptoms every 90 days from October 2021 through June 2025.

To measure olfactory function, the team used a clinical tool: the University of Pennsylvania Smell Identification Test (UPSIT). In this scratch-and-sniff evaluation, which is considered the gold standard of its kind, participants were asked to identify 40 scents by selecting the right multiple-choice option for each odor. A correct answer earned one point, and the total UPSIT score was compared with a database of thousands of healthy volunteers of the same sex and as. Based on the results, smelling ability was characterized as normal, mildly impaired, moderately impaired, severely impaired, or lost altogether.

“These results suggest that health care providers should consider testing for loss of smell as a routine part of post-COVID care,” said Horwitz. “While patients may not notice right away, a dulled nose can have a profound impact on their mental and physical well-being.”

Experts are now exploring ways to restore smelling ability after having COVID-19, such as vitamin A supplementation and olfactory training to “rewire” the brain’s response to odors. Having a deeper understanding of how the coronavirus affects the brain’s sensory and cognitive systems may help refine these therapies, notes Horwitz.

Horwitz cautions that the study team did not directly assess loss of taste, which often accompanies problems with smell. In addition, it is possible that some uninfected participants were misclassified due to the lack of universal testing for the virus. This may help explain the surprisingly high rate of hyposmia identified in those without a supposed history of COVID-19, she says.   

Reference:

Horwitz LI, Becker JH, Huang W, et al. Olfactory Dysfunction After SARS-CoV-2 Infection in the RECOVER Adult Cohort. JAMA Netw Open. 2025;8(9):e2533815. doi:10.1001/jamanetworkopen.2025.33815.

Powered by WPeMatico

Routine Asthma Screening Shows Benefits in Communities with High Asthma Prevalence: ERS Study

Researchers were able to identify more patients with asthma in specific communities by screening all children during routine wellness visits and asking about potential home environmental triggers, according to new research.

The authors of an abstract, “Screening for Asthma and Related Environmental Risks in a High-Risk Pediatric Populations: A Descriptive Analysis of Universal Screening,” will present their findings during the American Academy of Pediatrics 2025 National Conference & Exhibition at the Colorado Convention Center Sept. 26-30.

Authors identified a community that already showed a high prevalence of asthma cases and started universally screening all pediatric patients.

“Although common in children and with significant morbidity, asthma is highly treatable if diagnosed early and approached with a holistic lens that includes identifying and addressing environmental triggers,” said study author Karen Ganacias, MD, MPH, MedStar Health pediatrician and assistant professor of pediatrics at Georgetown University School of Medicine. “In populations with high asthma prevalence, routine screening for asthma symptoms and modifiable home environmental triggers can be an important first step to improving outcomes and decreasing disparities.”

Asthma is often underdiagnosed, particularly in children, and ongoing research is being conducted to identify environmental triggers in the home, such as mold, rodents or roaches.

The MedStar Health Kids Medical Mobile Clinic (KMMC) designed and integrated an Asthma Risk and Control Screen (ARCS) that evaluated 650 children ages two and older who had at least one well child visit between January 2021 and December 2024. Of that, 35% of individuals with no previous diagnosis of asthma reported at least one asthma risk factor, and 24% of those individuals were subsequently diagnosed with asthma based on further clinical findings.

Those who screened as positive for asthma reported coughing or shortness of breath at night, previous use of an inhaler, or exercise intolerance due to difficulty with breathing.

The study also found a high prevalence of poor housing quality in children in this population, about 41%, even higher, at 52%, for those that screened positive on the asthma symptom screen. The clinic has since developed a partnership with a home visiting program to remediate environmental triggers for children with asthma, as well as a medical-legal partnership to help advocate for safe and healthy housing.

The authors observe that children with asthma are more likely to miss school days, participate less in activities and sports, and have irregular sleep.

“Asthma is often diagnosed late or not at all because parents may not think of certain symptoms such as night-time cough or needing to stop activity to catch your breath, as being related to asthma,” said study author Janine A. Rethy, MD, MPH, division chief of Community Pediatrics at MedStar Health and associate professor at Georgetown University School of Medicine.

“There are also many environmental triggers in the home that may contribute to these symptoms and which a pediatrician should know about to help understand triggers and incorporate into a treatment plan. This study can open the conversation for screening for asthma and related environmental triggers for all children, especially when there is a high prevalence of asthma in the community.”

Reference:

Researchers find benefit in routine asthma screening in communities with high asthma prevalence, American Academy of Pediatrics, Meeting: American Academy of Pediatrics 2025 National Conference & Exhibition.

Powered by WPeMatico

NEET PG admissions 2025: BFUHS releases speciality-wise fee structure, tentative seat matrix, check complete details

Punjab: The Baba Farid University of Health Sciences (BFUHS) recently invited applications for PG medical admissions 2025 in the state.

All the interested candidates willing to take admission to MD/MS/PG Diploma, DNB Post Graduate Diploma in Sports Medicine and Six months training in Ultrasonography Courses are advised to take note of all the fees and seat matrix details as mentioned below according to the prospectus issued by the university.

Application Fee:

(i) Admission Application Fee of Rs. 5000 +18% GST (Rs. 5900/-) will be deposited through online payment gateway only. SC candidates will deposit fee of Rs. 2500+18% GST (Rs. 2950).

(ii) Only those Admission Application Forms will be considered for counseling, fee for which has been deposited by due date/time.

(iii) No request for accepting the deposition of application fee shall be considered after due date/time.

(iv) Admission/application fee once deposited in University Account will not be refunded/adjusted in any case. 

ELIGIBILITY / INSTRUCTIONS FOR NRI CANDIDATES

1. The NEET PG qualified candidates who seeks to apply under NRI quota seats, have to obtain provisional Eligibility/equivalency certificate from the BFUHS, Faridkot by appearing physical in the admission branch of BFUHS, Faridkot and will have to apply on prescribed format available on university website alongwith prescribed fee for NRI seats. 

2. For ascertaining the eligibility relevant documents including foreign Country Passport or Green Card or Permanent Resident Card or Proof of Residency of Foreign Country issued by competent authority or OCI/PIO Card issued by the Government of India shall be taken into consideration. 

3. The admission under NRI category shall be strictly according to preference category wise merit as per Punjab Govt. notification/instructions. 

4. The following is the procedure of admission under NRI Category :

(i) Application form for issuing of Eligibility/ Equivalency certificate is available in the Admission Branch BFUHS, Faridkot and can be downloaded from University website.

(ii) Eligibility

* NRI who passed MBBS

* Must have completed internship as per NMC

* Must be qualified- NEET-PG-2025

(iii) Candidate must be registered with MCI /State Medical Council and must have recognition Certificate of MBBS/Equivalent Degree from MCI. 

(iv) After getting Eligibility/ Equivalency certificate, candidate has to apply on prescribed application form upto stipulated period to the University for Counselling for admission to PG Medical Courses under NRI quota in Private colleges.

(v) Fee Structure in Private Colleges:

Fee Structure for NRI candidates:

Fee
Structure for NRI candidates:
Lump sum MD/MS (Clinical) US $ MD/MS
(Basic Sciences)US $
PG
Diploma US $
125,000/- 20,000/- 30,000/-
Installments MD/MS (Clinical) US $ MD/MS (Basic
Sciences)US $
PG Diploma US $
First
(at the time of Admission)
65000/- 10,000/- 15,000/-
Second
(after the one year of 1st Payment)
30,000/- 5,000/- 8,000/-
Third
(after the 2 year of 1st payment)
30,000/- 5,000/- 7,000/-

(a) The student will have to give a bank guarantee/surety bond for the residual fee, if he/she opts to pay the fee in installment as provided.

(b) Selected Candidates will have to deposit full/1st installment of the fee through university website from the foreign NRI account after seat allotment and before joining the allotted college.

(c) If payment made through Demand Draft, Demand Draft should be in favour of Registrar, Baba Farid University of Health Sciences, payable at Faridkot. 

(d) The payment should either be in US $ or is drawn from their own or parents NRE account along with bank certificate/statement showing that payment is drawn from candidate or parents account.

(e) The detail of bank account for the NRI candidates who will be selected for admission under NRI quota is as under: 

Beneficiary Name: REGISTRAR Baba Farid University of Health Sciences, Faridkot

Beneficiary A/c No. 078301005826

Beneficiary Bank: ICICI Bank Faridkot Punjab , India

Swift Code: ICICINBBNRI

IFSC Code: ICIC0000783

Branch Adress: BX5, Balmiki Chowk, Faridkot, 151203

Note: Registration /continuation fee @ 15% of tuition fee will be charged from NRI candidates except Adesh University, Bathinda and SGRD University, Amritsar. 

Seats in MD/MS/PG Diploma courses under NRI quota of various private colleges will be put up on University Website.

5. The following is the fee for getting Eligibility certificate and application fee under NRI Quota:-

a) Fee for getting Eligibility certificate = US $ 1500

b) Application Fee = US $ 1500

c) Application Form fee = Rs.3000/-

d) Eligibility certificate Form fee = Rs. 2500/-

INSTRUCTIONS REGARDING DEPOSITION OF FEE BY PROVISIONALLY SELECTED CANDIDATES IN ONLINE COUNSELLING – FEE AND SPECIALITIES (BASIC/CLINICAL)  

1. The provisionally selected candidates are required to deposit the requisite six months fee through university payment gateway in university account after logging into their login ID account and carry the payment receipt to the respective allotted institute. 

2. The Provisional Selection Slip will be generated only after the confirmation of deposition of fee.

Details of six month fee/minimum fee for 1st year to be collected from the provisionally selected candidates. 

Sr.No. Speciality Stream Govt. College/Hospital
six month fee (Rs.)
Private
Colleges Six month fee
Govt. Quota (Rs) Mgt. Quota (Rs) NRI
Quota 1st Installment
1. Anatomy Basic 50000 137500 137500 US$ 10000
2. Biochemistry Basic 50000 137500 137500 US$ 10000
3. Immuno
Haematology and Blood Transfusion
Basic 50000 137500 137500 US$ 10000
4. Microbiology Basic 50000 137500 137500 US$ 10000
5. Pharmacology Basic 50000 137500 137500 US$ 10000
6. Physiology Basic 50000 137500 137500 US$ 10000
7. Community
Medicine
Basic 50000 137500 137500 US$ 10000
8. Forensic
Medicine & Toxicology
Basic 50000 137500 137500 US$ 10000
9. Anaesthesiology Clinical 62500 342500 342500 US$ 65000
10. Skin
& STD
Clinical 62500 342500 342500 US$ 65000
11. General
Medicine
Clinical 62500 342500 342500 US$ 65000
12. Obstetrics
& Gynaecology
Clinical 62500 342500 342500 US$ 65000
13. Ophthalmology Clinical 62500 342500 342500 US$ 65000
14. Orthopedics Clinical 62500 342500 342500 US$ 65000
15. ENT Clinical 62500 342500 342500 US$ 65000
16. Pathology Clinical 62500 342500 342500 US$ 65000
17. Paediatrics Clinical 62500 342500 342500 US$ 65000
18. Psychiatry Clinical 62500 342500 342500 US$ 65000
19. Radio-diagnosis Clinical 62500 342500 342500 US$ 65000
20. General
Surgery
Clinical 62500 342500 342500 US$ 65000
21. Radiotherapy Clinical 62500 342500 342500 US$ 65000
22. TB
& Chest
Clinical 62500 342500 342500 US$ 65000
23. Diploma
in Anaesthesia (DA)
Clinical 62500 205000 205000 US$ 15000
24. Diploma
in Child Health (DCH)
Clinical 62500 205000 205000 US$ 15000
25. PGDSM 20000
26. Ultrasonography
Training
Training 10000 50000 50000
27. DNB
Courses
37500

 

FEE AND PENALTY CLAUSE. 

1. Candidate has to deposit security amount through online University payment gateway as per Punjab Government notification. 

2. Candidate’s who will not opt/forgo the seats in first counseling or have not attended the 1st counseling but are registered with the BFUHS, shall still be eligible for 2nd round of counseling of State of Punjab.  

3. Candidate’s who will surrender the seat in writing after joining in 1st round of online  counseling within stipulated period and who will not participate in any subsequent rounds, their all fee will be refunded without any penalty. 

4. The Punjab Govt. notification for PG admission 2025 and terms and conditions as contained on the website www.mcc.nic.in will be followed in letter and spirit. 

5. Candidates are advised to keep in touch with the BFUHS university website and Medical Counselling Committee website for further notices, process of counselling and updates.

6. The Security Deposit of candidates who have been allotted a seat in the Second Round or subsequent rounds but do not join the respective institution or surrender the seat due to any unforeseen reason, will be forfeited. Also, the Security Deposit will be forfeited if the admission gets cancelled due to any reason. E.g. in case the candidates gives wrong information at the time of registration on the basis of which a seat may be allotted and later cancelled by the Admission Authorities or the candidate fails to produce the required documents at the time of admission (within stipulated time). 

7. Candidate to whom seat is allotted during 2nd /subsequent round but they do not join the seat, penalty shall be imposed. Terms and conditions regarding penalty/forfeiture of security deposit shall be followed strictly as per Gazettee of India notification no. No.MCI-18(1)/2018-Med./100818 dated 05.04.2018.

8. Candidates who have joined the allotted seat in Round 3 and further rounds of counselling will not be allowed to resign and will also be ineligible to take part in further rounds of any type of counselling as per directions of Hon’ble Supreme Court of India dated 16.12.2021 passed in Special Leave to Appeal (C) No. 10487 of 2021 Nihila P.P Vs Medical Counselling Committee and ors. 

9. Candidates who will not join the allotted seat in Round 2 will be eligible for further rounds of counselling subject to forfeiture of security deposit and fresh registration and fresh depositing of refundable security deposit in 3rd round only.

10. Under the following circumstances the refundable security deposit will be forfeited :

i. Candidate allotted a seat in round 1 & not upgraded in round 2, but surrenders the seat after stipulated time given for free exit.

ii. Where a Candidate has been allotted a seat in Round 2 or subsequent rounds and does not report at the allotted college/hospital to complete the admission process. 

iii. The Security Deposit will be forfeited if the admission gets cancelled after allotment due to any reason. E.g., in case the candidate gives wrong information at the time of registration on the basis of which a seat may be allotted and later cancelled by the Admission Authorities at the time of reporting or fails to produce the required documents at the time of admission or any other valid reason 

Tentative distribution of seats for admission to MD/MS/PG Diploma courses, session 2025. 

Government Medical College, Patiala (MD/MS Seats)

Government
Medical College, Patiala
Name of Specialty
Total Seats
AIQ (50%)
State Quota (50%) IP
State Quota (50%) SC
State Quota (50%) BC
State Quota (50%) PWD (IP)
State Quota (50%) EWS
Total State Seats
Anaesthesia
7
4
3
2
1
0
0
General Medicine
12
6
6
5
1
0
0
Obst. & Gynae
12
6
6
3
2
1
0
Paediatrics
7
4
3
1
1
1
0
Pathology
11
6
5
3
1
1
1
Psychiatry
3
1
2
2
0
0
0
Radio-diagnosis
9
4
5
3
1
1
1
Radiotherapy
2
1
1
1
0
0
0
Dermatology, Venerology
& Leprosy
5
2
3
3
0
0
0
Tuberculosis &
Respiratory Medicine
5
3
2
1
1
0
0
ENT
7
4
3
2
1
0
0
General Surgery
18
9
9
6
2
1
0
Opthalmology
6
3
3
2
1
0
0
Orthopaedics
8
4
4
3
1
0
1
Anatomy
7
3
4
3
1
0
1
Biochemistry
4
2
2
2
0
0
0
Preventive & Social
Medicine
2
1
1
0
1
0
0
Forensic Medicine
3
1
2
2
0
0
0
Microbiology
1
0
1
1
0
0
0
Pharmacology
5
3
2
0
1
1
0
Physiology
6
3
3
2
1
0
1
DA (Diploma in
Anaesthesia)
6
3
3
1
1
1
0
3

Government
Medical College, Amritsar
Name of Specialty
Total Seats
AIQ (50%)
State Quota (50%) IP
State Quota (50%) SC
State Quota (50%) BC
State Quota (50%) PWD (IP)
State Quota (50%) EWS
Total State Quota
Anaesthesia
9
5
4
1
1
1
0

General Medicine
16
8
8
5
2
0
0
Obst. & Gynae
9
5
4
3
1
0
0
Paediatrics
5
3
2
2
0
0
0
Pathology
7
4
3
2
1
0
1
Psychiatry
3
2
1
1
0
0
0
Radio-diagnosis
5
3
2
1
0
1
1
Dermatology, Venerology
& Leprosy
4
2
2
1
1
0
0
Tuberculosis &
Respiratory Medicine
4
2
2
1
1
0
0
ENT
6
3
3
2
1
0
0
General Surgery
13
6
7
5
2
0
0
Opthalmology
6
3
3
3
0
0
0
Orthopaedics
9
4
5
4
1
0
1
Anatomy
6
3
3
2
1
0
0
Biochemistry
2
1
1
0
1
0
0
Preventive & Social
Medicine
5
2
3
3
0
0
1
Forensic Medicine
4
2
2
1
1
0
0
Microbiology
7
3
4
3
1
0
1
Pharmacology
4
2
2
2
0
0
0
Physiology
4
2
2
2
0
0
0
DA (Diploma in
Anaesthesia)
6
3
3
1
1
1
0
DCH (Diploma in Child
Health)
4
2
2
2
0
0
0
2


Dayanand Medical College, Ludhiana (Private) (MD/MS Seats)
Name of Specialty
Total Seats
Government Quota IP
Government Quota SC
Government Quota BC
Government Quota PWD (IP)
Government Quota Total
Management Quota Open
Management Quota SC
Management Quota BC
Management Quota PWD
Management Quota NRI
Management Quota Total
Anaesthesia
15
3
2
1
1
7
2
2
1
1
2
General Medicine
16
5
2
1
0
8
3
2
1
0
2
Immuno Haematology &
Blood Transfusion
3
1
1
0
0
2
0
0
0
0
1
Obst. & Gynae
4
2
0
0
0
2
0
1
0
0
1
Paediatrics
8
3
1
0
0
4
2
1
0
0
1
Pathology
8
1
1
1
1
4
1
1
1
0
1
Psychiatry
3
2
0
0
0
2
0
0
1
0
0
Radio-diagnosis
10
3
2
0
0
5
2
2
0
0
1
Dermatology, Venerology
& Leprosy
2
1
0
0
0
1
0
1
0
0
Otorhinolaryngology (ENT)
2
0
0
0
1
1
0
0
0
0
1
General Surgery
8
2
1
1
0
4
2
1
0
0
1
Ophthalmology
1
0
1
0
0
1
0
0
0
0
0
Orthopaedics
5
2
0
0
0
2
1
1
0
0
1
Anatomy
2
0
1
0
0
1
1
0
0
0
0
Biochemistry
2
0
1
0
0
1
0
1
0
0
0
Preventive & Social
Medicine
3
0
0
0
1
1
0
1
0
0
1
Microbiology
3
1
0
1
0
2
0
0
0
0
1
Pharmacology
4
2
0
0
0
2
1
0
0
0
1
Physiology
2
1
0
0
0
1


Christian
Medical College & Hospital, Ludhiana
Name of Specialty
Total Seats
A IP
A SC
A BC
A PWD (IP)
B Minority
C NRI
Anaesthesia
10
4
1
0
0
4
Anatomy
2
1
0
0
0
1
Biochemistry
1
1
0
0
0
0
Dermatology, Venerology
& Leprosy
1
0
0
0
0
1
ENT
2
1
0
0
0
0
General Medicine
8
3
1
0
0
3
General Surgery
8
3
1
0
0
3
Microbiology
3
1
0
0
0
2
Obst. & Gynae
4
1
0
0
0
2
Ophthalmology
3
1
0
0
0
1
Orthopaedics
4
2
0
0
0
1
Paediatrics
9
3
1
0
0
4
Pathology
4
1
1
0
0
1
Pharmacology
3
2
0
0
0
1
Physiology
1
0
0
0
0
1
Radio-diagnosis
6
2
1
0
0
2
Radiotherapy
3
1
1
0
0
1
Preventive & Social
Medicine
4
1
1
0
0
1
1

Sri
Guru Ram Das University of Health Sciences, Sri Amritsar
Name of Specialty
Total Seats
General Quota IP
General Quota SC
General Quota BC
General Quota PWD (IP)
General Quota NRI (7.5%)
Sikh Minority Seats
General
Sikh Minority Seats NRI
(7.5%)
Anaesthesia
12
3
1
1
0
1
5
General Medicine
16
4
2
1
0
1
7
Obst. & Gynae
4
1
1
0
0
0
2
Paediatrics
6
2
1
0
0
0
3
Pathology
12
3
1
1
0
1
5
Radio-diagnosis
10
1
2
1
0
1
4
Dermatology, Venerology
& Leprosy
3
1
0
0
0
0
1
Tuberculosis &
Respiratory Medicine
3
1
0
0
0
0
1
ENT
3
1
1
0
0
0
1
General Surgery
18
5
3
0
0
1
8
Opthalmology
3
1
0
0
0
0
1
Orthopaedics
7
2
1
0
0
1
2
Anatomy
2
1
0
0
0
0
1
Biochemistry
3
0
1
0
0
0
2
Preventive & Social
Medicine
3
1
0
0
0
0
2
Microbiology
3
1
0
0
0
0
2
Pharmacology
4
1
0
0
0
1
1
Physiology
3
2
0
0
0
0
1
0

Adesh Institute of Medical Sciences & Research Bathinda
Name of Specialty
Total Intake
General Merit IP
General Merit SC
General Merit BC
General Merit PWD (IP)
Total GM
Open Merit Open
Open Merit SC
Open Merit BC
Open Merit PWD
Total OM
General Surgery
10
5
0
0
0
5
2
2
1
0
Obst. & Gynae
6
2
0
1
0
3
1
1
0
1
ENT
2
1
0
0
0
1
0
1
0
0
Orthopaedics
5
1
0
1
0
2
1
1
0
1
Opthalmology
2
1
0
0
0
1
0
1
0
0
Psychiatry
3
1
0
0
0
1
0
1
0
1
Anaesthesia
12
5
0
1
0
6
1
3
1
1
Radio-diagnosis
7
2
0
1
0
3
1
2
0
1
Anatomy
2
1
0
0
0
1
1
0
0
0
Physiology
2
1
0
0
0
1
1
0
0
0
Biochemistry
2
1
0
0
0
1
1
0
0
0
Pharmacology
2
1
0
0
0
1
1
0
0
0
Pathology
4
2
0
0
0
2
1
1
0
0
Microbiology
2
1
0
0
0
1
1
0
0
0
Preventive & Social
Medicine
3
1
0
0
0
1
0
1
1
0
Dermatology, Venerology
& Leprosy
2
1
0
0
0
1
0
0
1
0
Immuno Haematology &
Blood Transfusion
2
1
0
0
0
1
0
0
1
0
Tuberculosis &
Respiratory Medicine
3
2
0
0
0
2
1
0
0
0
Paediatrics
2
1
0
0
0
1
0
0
1
0
General Medicine
3
2
0
0
0
2
1
0
0
0

Homi
Bhaba Cancer Hospital, Sangrur
Name of Specialty
Total Seats
AIQ (50%)
State Quota (50%) IP
State Quota (50%) SC
State Quota (50%) BC
State Quota (50%) PWD (IP)
State Quota (50%) EWS
Radiotherapy
4
2
2
1
1
0
0

Dr.
BR Ambedkar State Institute of Medical Sciences, SAS Nagar
Name of Specialty
Total Seats
AIQ (50%)
State Quota (50%) IP
State Quota (50%) SC
State Quota (50%) BC
State Quota (50%) PWD (IP)
State Quota (50%) EWS
Microbiology
4
2
2
1
1
0
0
Gian Sagar Medical College & Hospital, Ram Nagar, Rajpura
(Patiala)
Name of Specialty
Total Seats
Government Quota IP
Government Quota SC
Government Quota BC
Government Quota PWD (IP)
Government Quota Total
Management Quota Open
Management Quota SC
Management Quota BC
Management Quota PWD
Management Quota NRI
Management Quota Total
Pathology
5
1
1
0
0
2
1
1
0
0
1

Obst. & Gynae
3
2
0
0
0
2
0
0
0
0
1

Netaji
Subhas National Inst. of Sports, Patiala
Sr. No.
Name of Specialty
Total Seats
IP
SC
BC
PWD (IP)
1
Post Graduation Diploma in
Sports Medicine
3
0
1
1
Six Months Training in Ultrasonography
Sr. No.
Batch
Name of College
Total Seats
IP
SC
BC
PWD (IP)
1
Batch -A
Govt. Medical College,
Amritsar
6
4
2
0

2
Batch -B
Govt. Medical College,
Amritsar
6
4
1
1

3
Batch -A
Govt. Medical College,
Patiala
6
4
1
1

4
Batch -B
Govt. Medical College,
Patiala
6
2
2
1

DMC, Ludhiana
Government
Quota (IP)
Management
Quota
Sr. No.
Batch
Total Seats
IP
SC
BC
PWD (IP)
Total
Open
SC
BC
PWD
NRI
Total
1
1
2
0
1
0
0
1
0
1
0
0
0
1
2
2
2
1
0
0
0
1
0
0
0
0
1
1
SGRD Inst. of Medical Sciences, Amritsar
General
Quota as per Punjab Govt. Notification
Sikh
Minority Management Seats
Sr. No.
Batch
Total Seats
IP
SC
BC
PWD (IP)
NRI
Total
Open
SC
BC
PWD
NRI
Total
3
1
4
0
0
0
1
1
2
1
0
0
0
1
2
4
2
4
0
1
1
0
0
2
2
0
0
0
0
2

To view the full official notice click here: https://medicaldialogues.in/pdf_upload/prospectus-302575.pdf

Powered by WPeMatico

Experts warn federal cuts may extinguish momentum in tobacco control

A new commentary paper in Nicotine and Tobacco Research argues that recent cuts to the National Institutes of Health, including about $2 billion in terminated research grants and a $783 million cut to research funding linked to diversity and inclusion initiatives, will have a dramatically negative effect on efforts to combat tobacco usage and health disparities in the United States.

Powered by WPeMatico

Experts warn federal cuts may extinguish momentum in tobacco control

A new commentary paper in Nicotine and Tobacco Research argues that recent cuts to the National Institutes of Health, including about $2 billion in terminated research grants and a $783 million cut to research funding linked to diversity and inclusion initiatives, will have a dramatically negative effect on efforts to combat tobacco usage and health disparities in the United States.

Powered by WPeMatico

10-year clinical trial report finds radiation comparable to surgery for early-stage non-small cell lung cancer

A new clinical trial report finds that stereotactic radiation therapy offers long-term survival outcomes comparable to surgery for patients with small, early-stage non-small cell lung cancer (NSCLC). Patients in the study who received radiation also reported fewer side effects after treatment.

Powered by WPeMatico

10-year clinical trial report finds radiation comparable to surgery for early-stage non-small cell lung cancer

A new clinical trial report finds that stereotactic radiation therapy offers long-term survival outcomes comparable to surgery for patients with small, early-stage non-small cell lung cancer (NSCLC). Patients in the study who received radiation also reported fewer side effects after treatment.

Powered by WPeMatico

Ketamine deaths have increased 20-fold since 2015 with mixing drugs on the rise, UK analysis finds

Deaths due to illicit ketamine use have increased 20-fold since 2015—but these deaths are increasingly occurring in complex polydrug settings, raising doubts over whether single-substance drug policies can reduce harms.

Powered by WPeMatico

Hidden genetic risk could delay diabetes diagnosis for Black and Asian men

A common but often undiagnosed genetic condition may be causing delays in type 2 diabetes diagnoses and increasing the risk of serious complications for thousands of Black and South Asian men in the UK—and potentially millions worldwide.

Powered by WPeMatico